Biomark Diagnostics Statistics
Total Valuation
BMKDF has a market cap or net worth of 25.15 million. The enterprise value is 24.37 million.
| Market Cap | 25.15M |
| Enterprise Value | 24.37M |
Important Dates
The next estimated earnings date is Thursday, November 27, 2025.
| Earnings Date | Nov 27, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 105.09M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +8.42% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 53.63M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 221.49 |
| PB Ratio | 25.77 |
| P/TBV Ratio | 25.77 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -19.32 |
| EV / Sales | 212.62 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -31.31 |
Financial Position
The company has a current ratio of 1.85, with a Debt / Equity ratio of 0.77.
| Current Ratio | 1.85 |
| Quick Ratio | 1.85 |
| Debt / Equity | 0.77 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.97 |
| Interest Coverage | -35.78 |
Financial Efficiency
Return on equity (ROE) is -504.79% and return on invested capital (ROIC) is -71.73%.
| Return on Equity (ROE) | -504.79% |
| Return on Assets (ROA) | -62.79% |
| Return on Invested Capital (ROIC) | -71.73% |
| Return on Capital Employed (ROCE) | -128.50% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.08 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +21.65% in the last 52 weeks. The beta is -0.35, so BMKDF's price volatility has been lower than the market average.
| Beta (5Y) | -0.35 |
| 52-Week Price Change | +21.65% |
| 50-Day Moving Average | 0.25 |
| 200-Day Moving Average | 0.19 |
| Relative Strength Index (RSI) | 56.54 |
| Average Volume (20 Days) | 2,973 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BMKDF had revenue of 113,571 and -1.26 million in losses. Loss per share was -0.01.
| Revenue | 113,571 |
| Gross Profit | 113,571 |
| Operating Income | -1.35M |
| Pretax Income | -1.26M |
| Net Income | -1.26M |
| EBITDA | -1.34M |
| EBIT | -1.35M |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 1.54 million in cash and 752,888 in debt, giving a net cash position of 782,694.
| Cash & Cash Equivalents | 1.54M |
| Total Debt | 752,888 |
| Net Cash | 782,694 |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 975,969 |
| Book Value Per Share | 0.01 |
| Working Capital | 761,952 |
Cash Flow
In the last 12 months, operating cash flow was -775,858 and capital expenditures -2,222, giving a free cash flow of -778,080.
| Operating Cash Flow | -775,858 |
| Capital Expenditures | -2,222 |
| Free Cash Flow | -778,080 |
| FCF Per Share | n/a |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -1,188.12% |
| Pretax Margin | -1,110.44% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BMKDF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -8.42% |
| Shareholder Yield | n/a |
| Earnings Yield | -5.01% |
| FCF Yield | -3.09% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BMKDF has an Altman Z-Score of -1.35 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.35 |
| Piotroski F-Score | 2 |